Monday, September 20, 2021
- Advertisement -spot_img


anti-malarial drug hydroxychloroquine

WHO includes hydroxychloroquine in solidarity trial again

At a press conference in the WHO headquarters in Geneva, Director General Tedros Adhanom Ghebreyesus said: "On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.

Latest news

- Advertisement -spot_img
Telangana Today